The drug Lecanemab is offering new hope to people with early-stage Alzheimer’s disease. It’s been approved for use in the U.S. Dr. Heather Cooke from the Alzheimer’s Society of BC explains how it works, and when it might become available in Canada.
Global News Morning BC
Alzheimer’s drug approved in U.S.
More Videos
-
Cooking Together: Cinnamon Croissant Pain Perdu
-
Federal government cuts immigration targets
-
Business News: Bank of Canada interest rate cuts and did the feds go too far with immigration restrictions?
-
Palma’s Picks: Giving grief colour
-
Crime Stoppers Unsolved Cases
-
Health Matters: New report on state of Canadian health care systems
You are viewing an Accelerated Mobile Webpage.
View Original Article